Search clinical trials for: SHR0302

Total 30 results

Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

Non-radiographic Axial Spondyloarthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

First-in-Human Single Ascending Dose of SHR0302

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

Ankylosing Spondylitis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study of Human Substance Balance and Biotransformation of [14C]SHR0302

Rheumatoid Arthritis (RA)

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A SHR0302 BA Study on Healthy Subjects

Autoimmune Diseases

China
Henan Cancer Hospital

Not yet recruiting

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Peripheral T Cell Lymphoma

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Alopecia Areata

Alopecia Areata

China, Australia, United States
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study on the Bioavailability of SHR0302 in Healthy Subjects

Healthy Subjects

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis (MARBLE-23)

Atopic Dermatitis

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Recruiting

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

China, United States, Georgia, Poland, Ukraine
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Reistone Biopharma Company Limited

Active, not recruiting

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Alopecia Areata

China
Reistone Biopharma Company Limited

Completed

Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

China, Canada
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Psoriatic Arthritis

China
Reistone Biopharma Company Limited

Terminated

Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

Vitiligo

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment

Hepatic Impairment

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

Ulcerative Colitis

China, Poland, Ukraine, United States, Puerto Rico
Jiangsu HengRui Medicine Co., Ltd.

Completed

To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

Graft-versus-host Disease

China
Reistone Biopharma Company Limited

Completed

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Crohn's Disease

China, Poland, Ukraine, United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

The PK/PD Study of SHR0532 Tablets in Healthy Subjects

Hypertension
Sunhawk Vision Biotech, Inc.

Not yet recruiting

Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients

Corneal Erosion

Taiwan
Dreamhawk Vision Biotech, Inc.

Completed

Phase II Study of SHJ002 Sterile Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

Dry Eye Disease

Thailand, Australia, Taiwan
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

SHR0302 and Steroid as First Line Therapy for Chronic GVHD

Chronic GVHD

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects

Rheumatoid Arthritis

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Hypertension

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers

Rheumatoid Arthritis

China

3

Subscribe